Nifoxipam is an analytical reference substance and a new type of nitrobenzodiazepine sedative.

Nifoxipam can be used for short-term treatment of anxiety, insomnia, acute seizures, and sedation in hospitalized patients. However, it is currently only sold by online research chemical suppliers for use as recreational psychoactive substances.

Subjective effects include anxiety suppression, disinhibition, anticonvulsant, hypnosis, muscle relaxation, and amnesia. The effect of nifaxiam is very long-lasting, although its effect has been reported to be relatively weak.

It is important to note that sudden discontinuation of benzodiazepines can be potentially dangerous or life-threatening for people who use them regularly for a long period of time, sometimes resulting in seizures or death. It is highly recommended to gradually reduce the dose by gradually reducing the amount you take each day, rather than stopping abruptly.

As with other benzodiazepines, Nifaxepam has the potential for abuse and long-term use can lead to dependence. In addition, there is very little data on its metabolism, pharmacology and toxicity. If this substance is used, harm reduction practices are strongly recommended